Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission

被引：11

作者：

Mischnik, Alexander ^{[1
,2
,11
]}

Baumert, Philipp ^{[1
,2
]}

Hamprecht, Axel ^{[1
,3
]}

Rohde, Anna ^{[1
,4
]}

Peter, Silke ^{[1
,5
]}

Feihl, Susanne ^{[1
,6
]}

Knobloch, Johannes ^{[1
,7
]}

Goelz, Hanna ^{[1
,8
]}

Kola, Axel ^{[1
,4
]}

Obermann, Birgit ^{[1
,9
]}

Querbach, Christiane ^{[1
,6
]}

Willmann, Matthias ^{[1
,5
]}

Gebhardt, Friedemann ^{[1
,6
]}

Tacconelli, Evelina ^{[1
,10
]}

Gastmeier, Petra ^{[1
]}

Seifert, Harald ^{[1
]}

Kern, Winfried V. ^{[1
,2
]}

机构：

[1] German Ctr Infect Res DZIF, Hannover, Germany

[2] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany

[3] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany

[4] Chari Univ Hosp Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Inst Hyg & Environm Med, Berlin, Germany

[5] Univ Tubingen, Inst Med Microbiol & Hygiene, Tubingen, Germany

[6] Tech Univ Munich, Inst Med Microbiol Immunol & Hygiene, Munich, Germany

[7] Univ Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hygiene, Hamburg, Germany

[8] Univ Med Ctr Freiburg, Inst Med Microbiol & Hygiene, Freiburg, Germany

[9] Univ Hosp Schleswig Holstein, Inst Med Microbiol, Lubeck, Germany

[10] Univ Hosp Tubingen, Dept Internal Med 1, Div Infect Dis, Tubingen, Germany

[11] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 49卷 / 02期

关键词：

Extended-spectrum beta-lactamase; ESBL; beta-Lactam; Avibactam; AmpC; IN-VITRO ACTIVITY; BETA-LACTAMASES; AVIBACTAM; COLONIZATION; CEFTAZIDIME; BACTEREMIA;

D O I：

10.1016/j.ijantimicag.2016.10.013

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

As part of the multicentre Antibiotic Therapy Optimisation Study (ATHOS), minimum inhibitory concentrations (MICs) were determined for cephalosporins alone and in combination with the beta-lactamase inhibitors tazobactam, clavulanic acid and avibactam against third-generation cephalosporin-resistant Escherichia coli, Klebsiella spp. and Enterobacter spp. isolates collected in German hospitals. MIC50/90 values were 0.254mg/L for cefepime/tazobactam, 0.25-2 mg/L for ceftazidime/avibactam, 0.125-0.5mg/L for ceftaroline/avibactam, 0.5-4 mg/L for cefpodoxime/clavulanic acid and 0.25-1 mg/L for aztreonam/avibactam, depending on the underlying resistance mechanism and organism. Based on in vitro testing, beta-lactam antibiotics play an important role in the treatment of infections due to beta-lactamase-producing organisms. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

引用

页码：239 / 242

页数：4

共 50 条

[41] Occurrence and Genetic Characteristics of Third-Generation Cephalosporin-Resistant Escherichia coli in Swiss Retail Meat
Vogt, Debora
Overesch, Gudrun
Endimiani, Andrea
Collaud, Alexandra
Thomann, Andreas
Perreten, Vincent
MICROBIAL DRUG RESISTANCE, 2014, 20 (05) : 485 - 494
[42] Emergence of Third-Generation Cephalosporin-Resistant Morganella morganii in a Captive Breeding Dolphin in South Korea
Park, Seon Young
Lee, Kyunglee
Cho, Yuna
Lim, Se Ra
Kwon, Hyemin
Han, Jee Eun
Kim, Ji Hyung
ANIMALS, 2020, 10 (11): : 1 - 7
[43] The CREPE Score: A Predictive Tool for Third-Generation Cephalosporin-Resistant Enterobacterales Pneumonia in Community Settings
Khunkitti, Krisada
Sribenjalux, Wantin
Kuwatjanakul, Waewta
Arunsurat, Itthiphat
So-ngern, Apichart
Meesing, Atibordee
INFECTION AND DRUG RESISTANCE, 2023, 16 : 4159 - 4169
[44] Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant Escherichia coli Bloodstream Infections in Children
Cheng, Jie
Liu, Ya
Li, Shaojun
Pu, Kaibin
Yang, Lin
Tan, Liping
INFECTION AND DRUG RESISTANCE, 2024, 17 : 543 - 550
[45] High level of colonization with third-generation cephalosporin-resistant Enterobacterales in African community settings, Ghana
Obeng-Nkrumah, Noah
Hansen, Dennis Schroder
Awuah-Mensah, Georgina
Blankson, Nana Kweiba
Frimodt-Moller, Niels
Newman, Mercy Jemima
Opintan, Japheth Awuletey
Krogfelt, Karen Angeliki
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 106 (01)
[46] Risk Factors for Colonization with Third–Generation Cephalosporin–Resistant Enterobacteriaceae
C. Wendt
D. Lin
H. von Baum
Infection, 2005, 33 : 327 - 332
[47] Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany
Xanthopoulou, Kyriaki
Imirzalioglu, Can
Walker, Sarah, V
Behnke, Michael
Dinkelacker, Ariane G.
Eisenbeis, Simone
Gastmeier, Petra
Goelz, Hanna
Kaeding, Nadja
Kern, Winfried, V
Kola, Axel
Kramme, Evelyn
Lucassen, Kai
Mischnik, Alexander
Peter, Silke
Rohde, Anna M.
Rupp, Jan
Tacconelli, Evelina
Tobys, David
Vehreschild, Maria J. G. T.
Wille, Julia
Seifert, Harald
Higgins, Paul G.
ANTIBIOTICS-BASEL, 2022, 11 (10):
[48] Third-Generation Cephalosporin-Resistant Non-Typhoidal Salmonella Isolated from Human Feces in Japan
Saito, Satomi
Koori, Yoshio
Ohsakil, Yusuke
Osaka, Shunsuke
Oana, Kozue
Nagano, Yukiko
Arakawa, Yoshichika
Nagano, Noriyuki
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2017, 70 (03) : 301 - 304
[49] Epidemiology of third-generation cephalosporin-resistant community-acquired Enterobacteria isolated from elderly patients
Thibaut, S.
Caillon, J.
Marquet, A.
Grandjean, G.
Potel, G.
Ballereau, F.
MEDECINE ET MALADIES INFECTIEUSES, 2014, 44 (02): : 57 - 62
[50] Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!" REPLY
Butler, Mark S.
Gigante, Valeria
Sati, Hatim
Paulin, Sarah
Al-Sulaiman, Laila
Rex, John H.
Fernandes, Prabhavathi
Arias, Cesar A.
Paul, Mical
Thwaites, Guy E.
Czaplewski, Lloyd
Alm, Richard A.
Lienhardt, Christian
Spigelman, Melvin
Silver, Lynn L.
Ohmagari, Norio
Kozlov, Roman
Harbarth, Stephan
Beyer, Peter
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (04)

← 1 2 3 4 5 →